Title	Publication Date	Language	Citations
Meta-Analysis of Grazoprevir plus Elbasvir for Treatment of Hepatitis C Virus Genotype 1 Infection	2018/01/01	English	25
Group 2 innate lymphoid cells exhibit progressively higher levels of activation during worsening of liver fibrosis	2019/03/01	English	25
From Child-Pugh to MELD score and beyond: Taking a walk down memory lane	2022/01/01	English	25
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission	2021/03/01	English	25
Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes	2018/09/01	English	25
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?	2020/03/01	English	25
Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014	2018/03/01	English	24
The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review	2017/05/01	English	24
Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C	2017/03/01	English	24
Plants used for the treatment of icterus (jaundice) in Central India: A review	2019/09/01	English	24
Hepatoprotective Role of Thymol in Drug-Induced Gastric Ulcer Model	2018/11/01	English	24
Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure	2019/11/01	English	24
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients	2018/09/01	English	23
Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil	2019/11/01	English	23
Observational Cohort Study of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)	2017/01/01	English	23
Association between plasma bilirubin and mortality	2019/03/01	English	22
Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma	2017/07/01	English	22
Occult Hepatitis C Infection Among Hemodialysis Patients: A Prevalence Study	2017/07/01	English	22
Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis	2020/09/01	English	22
The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation	2021/07/01	English	22
Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population	2020/05/01	English	21
Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease	2021/03/01	English	21
The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study	2022/09/01	English	21
Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population	2019/09/01	English	21
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population	2020/11/01	English	21
What is Changing in Indications and Treatment of Focal Nodular Hyperplasia of the Liver. Is There any Place for Surgery?	2017/05/01	English	21
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization	2018/01/01	English	21
Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine	2017/09/01	English	21
Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4	2019/11/01	English	20
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis	2023/01/01	English	20